Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10647718
APP PUB NO 20170037047A1
SERIAL NO

15305409

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of general formula or salts or prodrugs thereof, are provided and described herein. The compounds are useful to expand hematopoietic stem cell and/or hematopoietic progenitor cell populations. Particularly, the hematopoietic cells are human cells. The compounds are also useful in the medical treatment of hematopoietic disorder/malignancy, an autoimmune disease and/or an inherited immune-deficient disease in a subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE DE MONTREALMONTREAL QC H3T 1J4

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gareau, Yves Notre-Dame-de-I'lle Perrot, CA 24 264
Gingras, Stéphane Montreal, CA 7 19
Sauvageau, Guy Montréal, CA 29 75

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 12, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 12, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00